Popular Johnson & Johnson beauty brands, such as Aveeno and Neutrogena, will live under a new company name, Kenvue, Johnson & Johnson announced on Thursday, September 28.

In late 2021, the company announced plans to place its personal care brands into a separate entity to create more targeted growth strategies. The new company will also include brands such as Listerine, Band-Aid, and Tylenol, and will fully separate from Johnson & Johnson in 2023.

The name Kenvue combines two separate words; “ken” meaning knowledge, an English word used primarily in Scotland, and “vue” meaning sight.

In a press release, Joaquin Duato, Johnson & Johnson’s CEO, stated, “Kenvue is poised to thrive as a standalone company with a leading portfolio of brands consumers love and trust. I’m confident in this team and excited to see what the future holds.”

Thibaut Mongon, the designated CEO of Kenvue, stated: “Unveiling the Kenvue brand is a defining moment for our stakeholders and an important part of the planned separation. We breathe life into some of the world’s most iconic and beloved brands every day, so we harnessed that same expertise, love, and energy into developing our new corporate identity.”

In recent years, Johnson & Johnson focused on the consumer health category, which generated revenue of $14.6 billion over the course of 2021. Once the company separation is complete, Kenvue will be sold in more than 100 countries.